Taho Pharmaceuticals Ltd. (TPE:6467)

Taho Pharmaceuticals Revenue

Taho Pharmaceuticals had revenue of 1.34M TWD in the quarter ending June 30, 2026, a decrease of -71.95%. This brings the company's total for the last twelve months to 1.98M, down -74.53% year-over-year. In the year 2025, Taho Pharmaceuticals had annual revenue of 8.41M. That makes Taho Pharmaceuticals the 46,453rd largest company in the world by revenue and 2,197th in Taiwan.

• Revenue (ttm): 1.98M
• Revenue Growth: -74.53%
• P/S Ratio: 5,357.20
• Revenue / Employee: 56.60K
• Employees: 35
• Market Cap: 10.61B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United State 8.33M 99.0%
• Japan 82.00K 1.0%

Fiscal year ended Dec 31, 2025 See the full Taho Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.41M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	1.07M	-5.29M	-83.23%
Dec 31, 2022	6.36M	-531.00K	-7.71%
Dec 31, 2021	6.89M	-5.51M	-44.45%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error